Simulations Plus (FRA:SD3) Beneish M-Score: -3.06 (As of Jul. 05, 2026)


FRA:SD3 Simulations Plus Inc FRA:SD3
67 GF Score
Price €15.80
GF Value €32.93
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Beneish M-Score?

Simulations Plus FRA:SD3 67 Beneish M-Score is -3.06 as of Jul. 05, 2026. GuruFocus rates FRA:SD3 with a GF Score™ of 67/100 and a GF Value™ of €32.93 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 630 Healthcare Providers & Services companies, Simulations Plus ranks better than 81.11% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.06 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Simulations Plus's Beneish M-Score or its related term are showing as below:

FRA:SD3' s Beneish M-Score Range Over the Past 10 Years
Min: -3.46   Med: -2.52   Max: -1.54
Current: -3.06

During the past 13 years, the highest Beneish M-Score of Simulations Plus was -1.54. The lowest was -3.46. And the median was -2.52.


Simulations Plus Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Simulations Plus's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus Beneish M-Score Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.11 -2.20 -3.00 -1.76 -2.66

Simulations Plus Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.60 -1.63 -2.66 -3.18 -3.06

FRA:SD3 vs TBRG, CARL, NRC: Beneish M-Score Comparison

For the Health Information Services subindustry, Simulations Plus's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Simulations Plus Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Simulations Plus's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Simulations Plus's Beneish M-Score falls into.


FRA:SD3
67GF Score
Simulations Plus Inc FRA:SD3
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Simulations Plus Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Simulations Plus for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0253+0.528 * 0.8939+0.404 * 0.6988+0.892 * 0.9469+0.115 * 0.9657
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9156+4.679 * -0.068227-0.327 * 1.5639
=-3.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Feb26) TTM:Last Year (Feb25) TTM:
Total Receivables was €15.37 Mil.
Revenue was 20.55 + 15.934 + 14.998 + 18.062 = €69.54 Mil.
Gross Profit was 13.657 + 9.421 + 8.456 + 11.559 = €43.09 Mil.
Total Current Assets was €57.16 Mil.
Total Assets was €123.93 Mil.
Property, Plant and Equipment(Net PPE) was €0.95 Mil.
Depreciation, Depletion and Amortization(DDA) was €5.69 Mil.
Selling, General, & Admin. Expense(SGA) was €26.46 Mil.
Total Current Liabilities was €10.44 Mil.
Long-Term Debt & Capital Lease Obligation was €0.31 Mil.
Net Income was 3.837 + 0.585 + -0.585 + -59.71 = €-55.87 Mil.
Non Operating Income was -0.027 + -0.009 + -0.008 + -68.484 = €-68.53 Mil.
Cash Flow from Operations was 5.425 + 3.662 + 4.799 + 7.224 = €21.11 Mil.
Total Receivables was €15.83 Mil.
Revenue was 21.535 + 17.826 + 16.928 + 17.153 = €73.44 Mil.
Gross Profit was 12.602 + 9.625 + 6.19 + 12.263 = €40.68 Mil.
Total Current Assets was €44.85 Mil.
Total Assets was €193.37 Mil.
Property, Plant and Equipment(Net PPE) was €1.56 Mil.
Depreciation, Depletion and Amortization(DDA) was €7.49 Mil.
Selling, General, & Admin. Expense(SGA) was €30.52 Mil.
Total Current Liabilities was €10.27 Mil.
Long-Term Debt & Capital Lease Obligation was €0.46 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(15.372 / 69.544) / (15.833 / 73.442)
=0.22104 / 0.215585
=1.0253

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(40.68 / 73.442) / (43.093 / 69.544)
=0.553906 / 0.619651
=0.8939

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (57.156 + 0.952) / 123.925) / (1 - (44.848 + 1.562) / 193.37)
=0.531103 / 0.759994
=0.6988

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=69.544 / 73.442
=0.9469

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(7.486 / (7.486 + 1.562)) / (5.692 / (5.692 + 0.952))
=0.827365 / 0.856713
=0.9657

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(26.457 / 69.544) / (30.516 / 73.442)
=0.380435 / 0.415512
=0.9156

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.313 + 10.442) / 123.925) / ((0.464 + 10.267) / 193.37)
=0.086786 / 0.055495
=1.5639

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-55.873 - -68.528 - 21.11) / 123.925
=-0.068227

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Simulations Plus has a M-score of -3.17 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -3.06 mean?
Simulations Plus (FRA:SD3) has a Beneish M-Score of -3.06 as of Jul. 05, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Simulations Plus and its competitors. According to the industry distribution chart, Simulations Plus ranks #119 out of 630 companies in the Healthcare Providers & Services industry, placing it in the top 18.9%.
Is Simulations Plus' Beneish M-Score too high?
Simulations Plus' current Beneish M-Score is -3.06. Based on the distribution chart, Simulations Plus ranks #119 out of 630 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Simulations Plus has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Beneish M-Score compare to TBRG and CARL?
According to the Healthcare Providers & Services industry distribution chart, Simulations Plus ranks #119 out of 630 companies for Beneish M-Score. This places Simulations Plus in the top 19% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Simulations Plus and its competitors. Simulations Plus's current Beneish M-Score is -3.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (FRA:SD3) is currently considered Significantly Undervalued. The stock's GF Value™ is €32.93, compared to a current price of €15.80 — trading 52% below its estimated fair value. The current Beneish M-Score is -3.06. Simulations Plus' overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Simulations Plus (FRA:SD3), the current Beneish M-Score is -3.06 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (FRA:SD3) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of €15.80 is trading 52% below its estimated GF Value™ of €32.93. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for FRA:SD3:

  • Beneish M-Score: -3.06
  • GF Value™: €32.93 vs. price of €15.80 (52% below fair value)
  • GF Score™: 67/100 with 7 warning signs

No single metric tells the full story. See the FRA:SD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Simulations Plus Business Description

Other Exchanges SLP:USA
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
67GF Score

Get the complete analysis for FRA:SD3

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.80
Price
€32.93
GF Value